EEE

LABORATORIO FARMACEUTICO ERFO

No trades
See on Supercharts
Market capitalization
‪10.12 M‬EUR
‪590.33 K‬EUR
‪5.74 M‬EUR
Beta (1Y)
0.20

About LABORATORIO FARMACEUTICO ERFO

Headquarters
Tirrena
Founded
2013
Website
ISIN
IT0005497885
FIGI
BBG018K91FP7
Laboratorio Farmaceutico Erfo SpA produces innovative food supplements. It offers study and production of multiple pharmaceutical forms: liquids, powders, granules, and tablets. Its brands include Diètnatural-Clinica del Slimming and Gianopharma. The company was founded in 2013 and is headquartered in Tirrena, Italy.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ERFO is 1.150 EUR — it has increased by 0.88% in the past 24 hours. Watch LABORATORIO FARMACEUTICO ERFO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange LABORATORIO FARMACEUTICO ERFO stocks are traded under the ticker ERFO.
ERFO stock is 6.99% volatile and has beta coefficient of 0.20. Track LABORATORIO FARMACEUTICO ERFO stock price on the chart and check out the list of the most volatile stocks — is LABORATORIO FARMACEUTICO ERFO there?
Yes, you can track LABORATORIO FARMACEUTICO ERFO financials in yearly and quarterly reports right on TradingView.
ERFO stock has risen by 0.88% compared to the previous week, the month change is a 0.88% rise, over the last year LABORATORIO FARMACEUTICO ERFO has showed a 2.68% increase.
ERFO net income for the last quarter is ‪120.08 K‬ EUR, while the quarter before that showed ‪437.79 K‬ EUR of net income which accounts for −72.57% change. Track more LABORATORIO FARMACEUTICO ERFO financial stats to get the full picture.
Like other stocks, ERFO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LABORATORIO FARMACEUTICO ERFO stock right from TradingView charts — choose your broker and connect to your account.
ERFO reached its all-time high on Aug 19, 2022 with the price of 3.300 EUR, and its all-time low was 0.880 EUR and was reached on Oct 26, 2023. View more price dynamics on ERFO chart.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LABORATORIO FARMACEUTICO ERFO technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LABORATORIO FARMACEUTICO ERFO stock shows the neutral signal. See more of LABORATORIO FARMACEUTICO ERFO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on LABORATORIO FARMACEUTICO ERFO future price: according to them, ERFO price has a max estimate of 1.47 EUR and a min estimate of 1.47 EUR. Watch ERFO chart and read a more detailed LABORATORIO FARMACEUTICO ERFO stock forecast: see what analysts think of LABORATORIO FARMACEUTICO ERFO and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LABORATORIO FARMACEUTICO ERFO EBITDA is ‪1.00 M‬ EUR, and current EBITDA margin is 17.93%. See more stats in LABORATORIO FARMACEUTICO ERFO financial statements.